Literature DB >> 22632585

A randomized clinical trial of chiropractic treatment and self-management in patients with acute musculoskeletal chest pain: 1-year follow-up.

Mette J Stochkendahl1, Henrik W Christensen, Werner Vach, Poul F Høilund-Carlsen, Torben Haghfelt, Jan Hartvigsen.   

Abstract

OBJECTIVE: We have previously reported short-term follow-up from a pragmatic randomized clinical trial comparing 2 treatments for acute musculoskeletal chest pain: (1) chiropractic treatment and (2) self-management. Results indicated a positive effect in favor of the chiropractic treatment after 4 and 12 weeks. The current article investigates the hypothesis that the advantage observed at 4 and 12 weeks would be sustained after 1 year. In addition, we describe self-reported consequences of acute musculoskeletal chest pain at 1-year follow-up.
METHODS: In a nonblinded, randomized controlled trial undertaken at an emergency cardiology department and 4 outpatient chiropractic clinics, 115 consecutive patients with acute chest pain of musculoskeletal origin were included. After the baseline evaluation, patients were randomized to 4 weeks of either chiropractic treatment or self-management, with posttreatment questionnaire follow-up 52 weeks later. The primary outcome measures were change in pain intensity (11-point box numerical rating scale) and self-perceived change in pain (7-point ordinal scale).
RESULTS: Both groups experienced decreases in pain, positive global, self-perceived treatment effect, and increases in the 36-Item Short Form Health Survey scores. No statistically significant differences were observed between groups at the 1-year follow-up, and we could not deduce a common trend in favor of either intervention.
CONCLUSIONS: At the 1-year follow-up, we found no difference between groups in terms of pain intensity and self-perceived change in chest pain in the first randomized clinical trial assessing chiropractic treatment vs minimal intervention for patients with acute musculoskeletal chest pain. Further research into health care utilization and use of prescriptive medication is warranted.
Copyright © 2012 National University of Health Sciences. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22632585     DOI: 10.1016/j.jmpt.2012.04.003

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  6 in total

Review 1.  Treatment efficacy for non-cardiovascular chest pain: a systematic review and meta-analysis.

Authors:  Jakob M Burgstaller; Boris F Jenni; Johann Steurer; Ulrike Held; Maria M Wertli
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

2.  The John A. Sweaney Lecture: Durbin, South Africa, April 2013, given by Dr Louis Sportelli. The 100 year test: can that tell us something?

Authors:  Louis Sportelli
Journal:  J Chiropr Humanit       Date:  2013-11-11

3.  Cost-effectiveness of chiropractic care versus self-management in patients with musculoskeletal chest pain.

Authors:  Mette Jensen Stochkendahl; Jan Sørensen; Werner Vach; Henrik Wulff Christensen; Poul Flemming Høilund-Carlsen; Jan Hartvigsen
Journal:  Open Heart       Date:  2016-05-04

Review 4.  Spine Care as a Framework for the Chiropractic Identity.

Authors:  Michael Schneider; Donald Murphy; Jan Hartvigsen
Journal:  J Chiropr Humanit       Date:  2016-11-04

5.  Spinal manipulative therapy, Graston technique® and placebo for non-specific thoracic spine pain: a randomised controlled trial.

Authors:  Amy L Crothers; Simon D French; Jeff J Hebert; Bruce F Walker
Journal:  Chiropr Man Therap       Date:  2016-05-16

6.  Non-cardiac chest pain patients in the emergency department: Do physicians have a plan how to diagnose and treat them? A retrospective study.

Authors:  Maria M Wertli; Tenzin D Dangma; Sarah E Müller; Laura M Gort; Benjamin S Klauser; Lina Melzer; Ulrike Held; Johann Steurer; Susann Hasler; Jakob M Burgstaller
Journal:  PLoS One       Date:  2019-02-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.